These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A classification based on T cell selection-related phenotypes identifies a subgroup of childhood T-ALL with favorable outcome in the COALL studies. Niehues T; Kapaun P; Harms DO; Burdach S; Kramm C; Körholz D; Janka-Schaub G; Göbel U Leukemia; 1999 Apr; 13(4):614-7. PubMed ID: 10214870 [TBL] [Abstract][Full Text] [Related]
3. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside. Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468 [TBL] [Abstract][Full Text] [Related]
4. Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia. Dibenedetto SP; Lo Nigro L; Mayer SP; Rovera G; Schilirò G Blood; 1997 Aug; 90(3):1226-32. PubMed ID: 9242556 [TBL] [Abstract][Full Text] [Related]
5. A child case of CD34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement. Nagata T; Higashigawa M; Nagai M; Zhang XL; Azuma E; Komada Y; Sakurai M Leuk Res; 1996; 20(11-12):983-5. PubMed ID: 9009257 [TBL] [Abstract][Full Text] [Related]
6. True histiocytic lymphoma following therapy for lymphoblastic neoplasms. Soslow RA; Davis RE; Warnke RA; Cleary ML; Kamel OW Blood; 1996 Jun; 87(12):5207-12. PubMed ID: 8652834 [TBL] [Abstract][Full Text] [Related]
7. Gene rearrangements in bone marrow cells of patients with acute myelogenous leukemia. Schmetzer HM; Braun S; Wiesner D; Duell T; Gerhartz HH; Mittermueller J Acta Haematol; 2000; 103(3):125-34. PubMed ID: 10940650 [TBL] [Abstract][Full Text] [Related]
8. Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine. Morita K; Jain N; Kantarjian H; Takahashi K; Fang H; Konopleva M; El Hussein S; Wang F; Short NJ; Maiti A; Sasaki K; Garcia-Manero G; Konoplev S; Ravandi F; Khoury JD; Jabbour E Am J Hematol; 2021 May; 96(5):589-598. PubMed ID: 33639000 [TBL] [Abstract][Full Text] [Related]
9. Lineage switch and multilineage involvement in two cases of pH chromosome-positive acute leukemia: evidence for a stem cell disease. Cuneo A; Balboni M; Piva N; Carli MG; Tomasi P; Previati R; Negrini M; Scapoli G; Spanedda R; Castoldi G Haematologica; 1994; 79(1):76-82. PubMed ID: 15378954 [TBL] [Abstract][Full Text] [Related]
10. Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature. Dunphy CH; Kitchen S; Saravia O; Velasquez WS Am J Hematol; 1996 Jan; 51(1):85-9. PubMed ID: 8571944 [TBL] [Abstract][Full Text] [Related]
11. Acute T-lymphoblastic leukemia relapsed with the character of myeloid/natural killer cell precursor phenotype: a case report. Hashimoto S; Toba K; Aoki S; Tsuchiyama J; Tsukada N; Takahashi H; Takahashi M; Aizawa Y Leuk Res; 2002 Feb; 26(2):215-9. PubMed ID: 11755472 [TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Ravindranath Y; Abella E; Krischer JP; Wiley J; Inoue S; Harris M; Chauvenet A; Alvarado CS; Dubowy R; Ritchey AK Blood; 1992 Nov; 80(9):2210-4. PubMed ID: 1384797 [TBL] [Abstract][Full Text] [Related]
13. Methotrexate polyglutamation may lack prognostic significance in children with B-cell precursor acute lymphoblastic leukemia treated with intensive oral methotrexate. Mantadakis E; Smith AK; Hynan L; Winick NJ; Kamen BA J Pediatr Hematol Oncol; 2002 Nov; 24(8):636-42. PubMed ID: 12439035 [TBL] [Abstract][Full Text] [Related]
14. Tetraploidy in acute myeloid leukemia secondary to large cell lymphoma. Kaplan SS; Rybka WB; Blom J; Shekhter-Levin S Leuk Lymphoma; 1998 Nov; 31(5-6):617-23. PubMed ID: 9922054 [TBL] [Abstract][Full Text] [Related]
15. T-cell acute lymphoblastic leukemia with t(1;18)(p36;q22). Kowal-Vern A; Melnyk A Cancer Genet Cytogenet; 1990 Nov; 50(1):31-3. PubMed ID: 2253188 [TBL] [Abstract][Full Text] [Related]
16. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity. Inhorn RC; Aster JC; Roach SA; Slapak CA; Soiffer R; Tantravahi R; Stone RM Blood; 1995 Apr; 85(7):1881-7. PubMed ID: 7661940 [TBL] [Abstract][Full Text] [Related]
17. CD7 expression does not predict for poor outcome in acute myeloblastic leukemia. Pillay Y; McLellan G; Davison G; Kelly S; Jacobs P Blood; 1995 Jun; 85(11):3357-9. PubMed ID: 7538826 [No Abstract] [Full Text] [Related]
18. Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia. Sievers EL; Lange BJ; Alonzo TA; Gerbing RB; Bernstein ID; Smith FO; Arceci RJ; Woods WG; Loken MR Blood; 2003 May; 101(9):3398-406. PubMed ID: 12506020 [TBL] [Abstract][Full Text] [Related]